LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 92 million patients in 130 countries.
We are a leader in thrombosis with a specific focus on cancer associated thrombosis (CAT) . We have worked with healthcare professionals to care for people with thrombosis for over 80 years. We strive to improve lives with high ethics and holistic support, setting new standards of care.
At LEO pharma we recognize that awareness and education is key in order to detect, treat and support patients developing Cancer Associated Thrombosis. We see this equally important for patients and as well as for those involved in treating the cancer.
With focus on thrombosis
With focus on educating patients
With focus on educating healthcare professionals
Impact of cancer associated thrombosis
Voices from those involved and affected by blood clots